key: cord-0430229-k2tin9l7 authors: Davis, James J.; Long, S. Wesley; Christensen, Paul A.; Olsen, Randall J.; Olson, Robert; Shukla, Maulik; Subedi, Sishir; Stevens, Rick; Musser, James M. title: Analysis of the ARTIC version 3 and version 4 SARS-CoV-2 primers and their impact on the detection of the G142D amino acid substitution in the spike protein date: 2021-09-28 journal: bioRxiv DOI: 10.1101/2021.09.27.461949 sha: 0b095928f17ba662bd55e99c7381e59e9c24c769 doc_id: 430229 cord_uid: k2tin9l7 The ARTIC Network provides a common resource of PCR primer sequences and recommendations for amplifying SARS-CoV-2 genomes. The initial tiling strategy was developed with the reference genome Wuhan-01, and subsequent iterations have addressed areas of low amplification and sequence drop out. Recently, a new version (V4) was released, based on new variant genome sequences, in response to the realization that some V3 primers were located in regions with key mutations. Herein, we compare the performance of the ARTIC V3 and V4 primer sets with a matched set of 663 SARS-CoV-2 clinical samples sequenced with an Illumina NovaSeq 6000 instrument. We observe general improvements in sequencing depth and quality, and improved resolution of the SNP causing the D950N variation in the spike protein. Importantly, we also find nearly universal presence of spike protein substitution G142D in Delta-lineage samples. Due to the prior release and widespread use of the ARTIC V3 primers during the initial surge of the Delta variant, it is likely that the G142D amino acid substitution is substantially underrepresented among early Delta variant genomes deposited in public repositories. In addition to the improved performance of the ARTIC V4 primer set, this study also illustrates the importance of the primer scheme in downstream analyses. Importance ARTIC Network primers are commonly used by laboratories worldwide to amplify and sequence SARS-CoV-2 present in clinical samples. As new variants have evolved and spread, it was found that the V3 primer set poorly amplified several key mutations. In this report, we compare the results of sequencing a matched set of samples with the V3 and V4 primer sets. We find that adoption of the ARTIC V4 primer set is critical for accurate sequencing of the SARS-CoV-2 spike region. The absence of metadata describing the primer scheme used will negatively impact the downstream use of publicly available SARS-Cov-2 sequencing reads and assembled genomes. A n a l y s i s o f t h e A R T I C v e r s i o n 3 a n d v e r s i o n 4 S A R S -C o V -2 p r i m e r s a n d t h e i r i m p a c t o n t h e d e t e c t i o n o f t h e G 1 4 2 D a m i n o a c i d s u b s t i t u t i o n i n t h e s p i k e p r o t e i D e p a r t m e n t o f C o m p u t e r S c i e n c e , U n i v e r s i t y o f C h i c a g o , C h i c a g o , I l l i n o i s , 6 0 6 3 7 R u n n i n g h e a d : A R T I C V 3 V e r s u s V 4 P r i m e r s * C o n t r i b u t e d e q u a l l y t o t h i s w o r k # A d d r e s s c o r r e s p o n d e n c e t o J a m e s J . D a v i s , P h . D . , D i v i s i o n o f D a t a S c i e n c e a n d L e a r n i n g , A r g o n n e N a t i o n a l L a b o r a t o r y , 9 7 0 0 S . C a s s A v e . , L e m o n t , I l l i n o i s , 6 0 4 3 9 T e l : 6 3 0 -2 5 2 -1 1 9 0 , E - m a i l : j j d a v i s @ a n l . g o v D i s c l o s u r e s : N o n e . A B S T R A C T T h e A R T I C N e t w o r k p r o v i d e s a c o m m o n r e s o u r c e o f P C R p r i m e r s e q u e n c e s a n d r e c o m m e n d a t i o n s f o r a m p l i f y i n g S A R S -C o V -2 g e n o m e s . T h e i n i t i a l t i l i n g s t r a t e g y w a s d e v e l o p e d w i t h t h e r e f e r e n c e g e n o m e W u h a n -0 1 , a n d s u b s e q u e n t i t e r a t i o n s h a v e a d d r e s s e d a r e a s o f l o T I C V 4 p r i m e r s e t i s c r i t i c a l f o r a c c u r a t e s e q u e n c i n g o f t h e S A R S -C o V -2 s p i k e r e g i o n . T h e a b s e n c e o f m e t a d a t a d e s c r i b i n g t h e p r i m e r s c h e m e u s e d w i l l n e g a t i v e l y i m p a c t t h e d o w n s t r e a m u s e o f p u b l i c l y a v a i l a b l e S A R S - C o v - 2 s e q u e n c i n g r e a d s a n d a s s e m b l e d g e n o m e s . O b s e r v a t i o n T h e A R T I C N e t w o r k i s a c o n s o r t i u m d e d i c a t e d t o p r o v i d i n g t o o l s t o s u p p o r t g l o b a l v i r a l e p i d e m i o l o g y e f f o r t s t h r o u g h l o w c o s t g e n o m i c s e q u e n c i n g ( h t t p s : / / a r t i c . n e t w o r k ) . E a r l y i n t h e S A R S - C o V - 2 p a n d e m i c , t h e c o n s o r t i u m d e v e l o p e d a s e t o f p r i m e r s ( A R T I C V 1 ) d e s i g n e d t o c o m p l e t e l y s e q u e n c e t h e S A R S - C o V - 2 g e n o m e w i t h o v e r l a p p i n g 4 0 0 - b p a m p l i c o n s . S h o r t c o m i n g s i d e n t i f i e d i n t h e V 1 p r o t o c o l , p r i m a r i l y d u e t o r e g i o n s o f a m p l i c o n d r o p o u t , l e d t o t w o m o r e i t e r a t i o n s o f p r i m e r d e s i g n , w h i c h r e s u l t e d i n A R T I C V 3 b e i n g u s e d b y m a n y l a b o r a t o r i e s i n 2 0 2 0 a n d i n t o 2 0 2 1 ( 1 ) . A s t h e C O V I D - 1 9 p a n d e m i c c o n t i n u e d , n e w v a r i a n t s e m e r g e d w i t h u n i q u e m u t a t i o n s a n d e n h a n c e d t r a n s m i s s i b i l i t y ( 2 - 4 ) . S o m e o f t h e s e m u t a t i o n s o c c u r r e d i n p r i m e r b i n d i n g s i t e s i n g e n e s t h a t e n c o d e k e y p r o t e i n s s u c h a s s p i k e p r o t e i n , r e s u l t i n g i n a m p l i c o n d r o p o u t a n d p o o r s e q u e n c e c o v e r a g e i n c r i t i c a l r e g i o n s . A R T I C V 4 w ad i n g G 1 4 2 D ( D e l t a ) i n t h e 2 _ R i g h t p r i m e r , t h e 2 4 1 / 2 4 3 d e l ( B e t a ) t h a t o c c u r s i n t h e 7 4 _ L e f t p r i m e r , a n d t h e K 4 1 7 N ( B e t a ) o r K 4 1 7 T ( G a m m a ) w h i c h o c c u r i n t h e 7 6 _ L e f t p r i m e r ( h t t p s : / / c o m m u n i t y . a r t i c . n e t w o r k / t / s a r s - c o v - 2 - v e r s i o n - 4 - s c h e m e - R T I C p r i m e r s e t s t h r o u g h o u t t h e p a n d e m i c , w e e l e c t e d t o v a l i d a t e t h e A R T I C V 4 p r i m e r s e t p r i o r t o a d o p t i n g t h e n e w p r o t o c o l . W e c h o s e a r a n d o m s e t o f 6 6 3 S A R S -C o V - B V - B R C ) ( h t t p s : / / w w w . b v - b r c . o r g ) , w h i c h f o l l o w s t h e O n e - C o d e x w o r k f l o w ( h t t p s : / / g i t h u b . c o m / o n e c o d e x / s a r s - c o v - 2 ) . T h e w o r k f l o w u s e s s e q t k v e r s i o n 1 . 3 - r 1 1 6 f o r q u a l i t y t r i m m i n g ( h t t p s : / / g i t h u b . c o m / l h 3 / s e q t k . g i t ) ; m i n i m T I C V 4 ( h t t p s : / / c o m m u n i t y . a r t i c . n e t w o r k / t / s a r s -c o v -2 -v e r s i o n -4 -s c h e m e -r e l e a s e / 3 1 2 ) , w e o b s e r v e a n a r e a o f s l i g h t l y l o w e r c o v e r a g e i n t h e V 4 s e q u e n c e s a t a p p r o x i m a t e n u c l e o t i T h e s e d a t a b a s e s h a v e b e e n i n d i s p e n s a b l e f o r e p i d e m i o l o g i c a l a n a l y s e s , e a r l y i d e n t i f i c a t i o n o f v a r i a n t s o f c o n c e r n , a n d d o w n s t r e a m t r a n s l a t i o n a l r e s e a r c h a c t i v i t i e s s u c h a s v a c c i n e f o r m u l a t i o n . F r o m J u n e 2 0 2 1 t h r o u g h A u g u s t 2 0 2 1 , t h e r a p i d i n c r e a s e i n t h e G 1 4 2 D a m i n o a c i d s u b s t i t u t i o n p r e s e n t i n D e l t a v a r i a n t s i n p u b l i c r e p o s i t o r i e s a p p e a r e d t o i n d i c a t e a r a p i d e v o l u t i o n a r y s w e e p ( F i g C o V -2 g e n o m e s i s a n i m p o r t a n t c o n s i d e r a t i o n f o r i n t e r p r e t i n g e p i d e m i o l o g i c a l d a t a a n d i d e n t i f y i n g v a r i a n t s o f c o n c e r D i s t r i b u t i o n o f P a n g o l i n l i n e a g e s i n t h e s e t o f 6 6 3 s a m p l e s t h a t w e r e s e q u e n c e d u s i n g e i t h e r t h e A R T I C v e r s i o n 3 o r v e r s i o n 4 a n d b l u e c i r c l e s a r e l e f t p r i m e r s . ( D ) T h e f r a c t i o n o f B . 1 . 6 1 7 . 2 s e q u e n c e s i n G I S A I D w i t h ( b l u e ) a n d w i t h o u t ( o r a n g e ) G 1 4 2 D t h r o u g h A u g u s t 3 1 , 2 0 2 1 . ( E ) F r e q u e n c y o f L 4 5 2 R ( g r a y ) , D 9 5 0 N ( b l u e ) , a n d G 1 4 2 D ( o r a n g e ) a m i n o a c i d s u b s t i t u t i o n s o b s e r v e d i n S A R S -C o V -2 -p o s i t i v e s a m p l e Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore Estimated transmissibility and impact of SARS-CoV-2 lineage B. 1.1. 7 in England Citiid-Nihr BioResource Covid-19 Collaboration AM Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Sequence Analysis of 20,453 Severe Acute Respiratory Syndrome Coronavirus 2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern Trajectory of Growth of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in Minimap2: pairwise alignment for nucleotide sequences The sequence alignment/map format and SAMtools An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology GISAID: Global initiative on sharing all influenza data-from vision to reality The international nucleotide sequence database collaboration Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus